4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-18-001320
Options or other derivatives
- Director acquired 96,375 shares (grant or award)
- Director returned 96,375 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −375 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +375 | 375 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −1,000 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −7,500 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
| SAXE JON S Director | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −35,000 | 0 | D | ||
| SAXE JON S Director | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | D | ||
Loading xslF345X03/form4-08312018_020838.xml…